Spore-forming probiotics for functional dyspepsia

Affiliations

¹ Belgian Centre for Evidence-Based Medicine, Cochrane Belgium, B-3000 Leuven, Belgium. Electronic address: patrick.mullie@skynet.be.
² Belgian Centre for Evidence-Based Medicine, Cochrane Belgium, B-3000 Leuven, Belgium.

Comment

Patrick Mullie et al. Lancet Gastroenterol Hepatol. 2021 Dec.

. 2021 Dec;6(12):982-983.

doi: 10.1016/S2468-1253(21)00340-X.

¹ Belgian Centre for Evidence-Based Medicine, Cochrane Belgium, B-3000 Leuven, Belgium. Electronic address: patrick.mullie@skynet.be.
² Belgian Centre for Evidence-Based Medicine, Cochrane Belgium, B-3000 Leuven, Belgium.

No abstract available

Conflict of interest statement

We declare no competing interests.

Spore-forming probiotics for functional dyspepsia - Authors' reply.
Wauters L, Vanuytsel T. Wauters L, et al. Lancet Gastroenterol Hepatol. 2021 Dec;6(12):983-984. doi: 10.1016/S2468-1253(21)00381-2. Lancet Gastroenterol Hepatol. 2021. PMID: 34774154 No abstract available.

Efficacy and safety of spore-forming probiotics in the treatment of functional dyspepsia: a pilot randomised, double-blind, placebo-controlled trial.
Wauters L, Slaets H, De Paepe K, Ceulemans M, Wetzels S, Geboers K, Toth J, Thys W, Dybajlo R, Walgraeve D, Biessen E, Verbeke K, Tack J, Van de Wiele T, Hellings N, Vanuytsel T. Wauters L, et al. Lancet Gastroenterol Hepatol. 2021 Oct;6(10):784-792. doi: 10.1016/S2468-1253(21)00226-0. Epub 2021 Aug 3. Lancet Gastroenterol Hepatol. 2021. PMID: 34358486 Clinical Trial.